J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Humira biosimilar scripts take off
Intra-Cellular launches 26% to record high, breaking out after depression drug scores big
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud